Goldiam International revenue fell 9% to ₹141.1 crore in Q1 FY23

Goldiam International Limited reported consolidated revenue of ₹141.1 crore in Q1 FY23, down 9% year on year, citing a higher-inflation environment in the United States, while its lab-grown diamond and jewellery sales increased fivefold from Q1 FY22.

Why did Goldiam International's Q1 FY23 revenue decline?

Goldiam International said consolidated revenue for the quarter ended June 30, 2022, declined 9% year on year to ₹141.1 crore. The company attributed the lower revenue to a higher-inflation scenario in the US, a key market for its diamond jewellery business.

The disclosure was made in the investor presentation accompanying the company's financial results for Q1 FY23. Goldiam filed the presentation with the National Stock Exchange of India under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Its NSE scrip code is GOLDIAM EQ.

The revenue movement highlights the sensitivity of an export-led jewellery manufacturer to conditions in its overseas retail markets. Goldiam supplies retailers, departmental stores and wholesalers, and its customer base includes markets in the US, Europe and Australia. The company did not provide a separate numerical split in the supplied material for the impact across each geography or customer category.

What did Goldiam International report on profitability and lab-grown sales?

Goldiam reported Q1 FY23 cash profit of ₹35.1 crore, compared with ₹37.2 crore in Q1 FY22. Cash profit in the presentation was defined as profit after tax plus depreciation, and the year-on-year comparison indicates a decline of ₹2.1 crore.

At the same time, the company reported that lab-grown diamond and jewellery sales grew fivefold between Q1 FY22 and Q1 FY23. Goldiam described this as evidence of growing demand for the segment, although the presentation excerpt did not disclose the absolute sales value of lab-grown products.

This combination of lower total consolidated revenue and rapid growth in a specific product category is relevant to the company's product mix. Goldiam operates across natural and lab-grown diamond jewellery, allowing it to address both parts of the diamond jewellery market through an integrated manufacturing and supply model.

How is Goldiam International positioned in the jewellery market?

Goldiam is an integrated manufacturer and supplier of gold, silver, platinum and diamond-studded jewellery, including products with natural and lab-grown diamonds. The company was established in 1986 and initially operated as an exporter of cut and polished diamonds before pivoting to diamond jewellery exports.

Its presentation identifies the company as a supplier to global retailers, departmental stores and wholesalers. Its operating model includes manufacturing and export activity, with the company describing itself as an original equipment manufacturer for large diamond jewellery retailers in the US.

The more recent February 2026 presentation also outlined a domestic retail strategy through an exclusive lab-grown jewellery brand. Goldiam said it considers brand-exclusive stores important for expanding its footprint across India, strengthening brand recall, controlling customer experience and maintaining consistent product presentation.

What is known about Goldiam International's retail presence?

Goldiam had 65 total showrooms, including six company-owned and company-operated showrooms, according to information in the supplied presentation material. A separate note, referring to the company's Q4 FY25 investor presentation, stated that the company had six showrooms in Mumbai.

The company also had a dedicated design team of 29 full-time employees as of March 31, 2025. These details point to a business that combines export-oriented manufacturing with a developing India-focused retail presence, particularly in lab-grown jewellery.

The available material does not provide store-level sales, retail revenue or the financial contribution of its domestic showroom network. It also does not state a target number of future stores. Investors therefore have limited disclosed data to measure the pace or economics of the retail expansion from the information provided.

How does the Q1 FY23 update matter to investors?

For investors, the Q1 FY23 update shows two distinct operating trends: consolidated revenue was affected by inflationary conditions in the US, while lab-grown diamond and jewellery sales recorded strong growth from a lower or undisclosed base. The cash-profit comparison also shows that profit generation, as defined by the company, was lower than in the corresponding quarter a year earlier.

The data should be assessed in the context of Goldiam's export exposure and its product mix. A company supplying overseas retailers can be influenced by consumer demand and broader retail conditions in destination markets. Meanwhile, lab-grown jewellery is a separately identified strategic category for Goldiam, both in its export offering and its India retail plans.

The supplied documents show that Goldiam continued to issue investor presentations for subsequent periods, including a presentation for the quarter and nine months ended December 31, 2025, and an FY26 presentation dated May 27, 2026. However, the supplied excerpts do not include the underlying FY26 revenue, profit or margin figures.

Conclusion

Goldiam's Q1 FY23 results recorded a 9% decline in consolidated revenue to ₹141.1 crore and a fall in cash profit to ₹35.1 crore, against a backdrop of higher US inflation. At the same time, fivefold growth in lab-grown diamond and jewellery sales indicated a meaningful shift within its product portfolio.

The next disclosures to watch are updates on Goldiam's plan to expand its India retail footprint through brand-exclusive stores, along with any reported store count, retail sales contribution and financial metrics for the lab-grown jewellery business. The company has continued to publish investor presentations, making future filings the relevant source for these operating details.